Get the Stockscreener App
6.28
2.28%
0.14
After Hours:
6.25
-0.03
-0.48%
Clene Inc stock is traded at $6.28, with a volume of 52,173.
It is up +2.28% in the last 24 hours and up +8.84% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$6.14
Open:
$6.18
24h Volume:
52,173
Relative Volume:
0.29
Market Cap:
$64.90M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-1.4081
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
+6.98%
1M Performance:
+8.84%
6M Performance:
+62.27%
1Y Performance:
+6.62%
1-Day Range:
$6.06
$6.56
1-Week Range:
$5.54
$6.56
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.28 | 63.45M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 5th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 13,095 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 4,015 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Published on: 2026-01-01 16:53:08 - moha.gov.vn
Nanotechnology Stocks To ResearchDecember 31st - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 8,096 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,138 Shares - MarketBeat
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 - Investing.com
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123 By Investing.com - Investing.com UK
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 6,831 Shares of Stock - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock By Investing.com - Investing.com Nigeria
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 3,350 Shares - MarketBeat
Clene Inc: Ugwumba sells $73k in CLNN stock - Investing.com
Nanotechnology Stocks To Follow TodayDecember 29th - MarketBeat
Short Interest in Clene Inc. (NASDAQ:CLNN) Increases By 47.4% - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Promising Nanotechnology Stocks To Follow NowDecember 22nd - MarketBeat
Promising Nanotechnology Stocks To Keep An Eye OnDecember 25th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnDecember 23rd - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 4,367 Shares of Stock - MarketBeat
Chidozie Ugwumba Sells 5,582 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Promising Nanotechnology Stocks To ResearchDecember 8th - MarketBeat
Have Insiders Sold Clene Shares Recently? - simplywall.st
This Insider Has Just Sold Shares In Clene - 富途牛牛
Will Clene Inc. Equity Warrant stock beat EPS estimatesWeekly Profit Summary & High Accuracy Investment Signals - Улправда
Is Clene Inc. Equity Warrant stock attractive for retirement portfoliosWeekly Profit Report & AI Driven Stock Price Forecasts - Улправда
Why Clene Inc. stock remains on buy lists2025 Retail Activity & Stock Portfolio Risk Management - Улправда
Promising Nanotechnology Stocks To Follow TodayDecember 19th - MarketBeat
Published on: 2025-12-19 17:52:46 - Bölüm Sonu Canavarı
What technical signals suggest for Clene Inc. stockMarket Movers & Daily Chart Pattern Signals - Улправда
Will Clene Inc. stock gain from strong economyJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - DonanımHaber
Can Clene Inc. Equity Warrant stock weather global recessionJuly 2025 Earnings & Safe Capital Investment Plans - DonanımHaber
How Clene Inc. stock performs in weak economyWeekly Market Report & Free Reliable Trade Execution Plans - Улправда
Is Clene Inc. Equity Warrant stock dividend yield sustainable2025 Stock Rankings & Long Hold Capital Preservation Tips - DonanımHaber
Published on: 2025-12-19 10:58:32 - Улправда
[Form 4] Clene Inc. Insider Trading Activity - Stock Titan
Chidozie Ugwumba Sells 56,577 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Will Clene Inc. Equity Warrant stock return to pre crisis levelsJuly 2025 Summary & Safe Capital Growth Trade Ideas - Улправда
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 9,921 Shares - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 2,884 Shares - MarketBeat
Chidozie Ugwumba Sells 5,816 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Chidozie Ugwumba Sells 10,907 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Street Watch: Will Clene Inc. Equity Warrant stock beat EPS estimatesWeekly Earnings Recap & AI Based Trade Execution Alerts - ulpravda.ru
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 37,235 Shares - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 72,748 Shares of Stock - MarketBeat
Clene Insider Sold Shares Worth $1,725,735, According to a Recent SEC Filing - marketscreener.com
Owner Ugwumba Sells 257,795 ($1.7M) Of Clene Inc [CLNN] - TradingView — Track All Markets
Nanotechnology Stocks To ConsiderDecember 18th - MarketBeat
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clene Inc Stock (CLNN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
Jan 02 '26 |
Sale |
5.73 |
4,015 |
23,006 |
766,480 |
| Ugwumba Chidozie | 10% Owner |
Dec 29 '25 |
Sale |
5.95 |
8,096 |
48,171 |
787,728 |
| Ugwumba Chidozie | 10% Owner |
Dec 30 '25 |
Sale |
6.03 |
4,138 |
24,952 |
783,590 |
| Ugwumba Chidozie | 10% Owner |
Dec 23 '25 |
Sale |
6.27 |
6,831 |
42,830 |
800,664 |
| Ugwumba Chidozie | 10% Owner |
Dec 26 '25 |
Sale |
6.32 |
3,350 |
21,172 |
795,824 |
| Ugwumba Chidozie | 10% Owner |
Dec 24 '25 |
Sale |
6.27 |
1,490 |
9,342 |
799,174 |
| Ugwumba Chidozie | 10% Owner |
Dec 19 '25 |
Sale |
6.45 |
5,582 |
36,004 |
387,568 |
| Ugwumba Chidozie | 10% Owner |
Dec 22 '25 |
Sale |
6.54 |
4,367 |
28,560 |
383,201 |
| Ugwumba Chidozie | 10% Owner |
Dec 04 '25 |
Sale |
6.73 |
72,748 |
489,594 |
521,620 |
| Ugwumba Chidozie | 10% Owner |
Dec 03 '25 |
Sale |
7.86 |
56,577 |
444,695 |
594,368 |
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):